Janney Montgomery Scott LLC Novo Cure LTD Transaction History

Janney Montgomery Scott LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$130.4 - $225.58 $4.94 Million - $8.54 Million	-37,861 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$124.11 - $190.17 $1.2 Million - $1.83 Million	-9,642 Reduced 20.3%	37,861 $5 Million
Q4 2020 Jan 25, 2021	BUY	$112.16 - $174.14 $5.33 Million - $8.27 Million	47,503 New	47,503 $8.22 Million
Q1 2020 Apr 30, 2020	SELL	$57.05 - $95.75 $580,084 - $973,586	-10,168 Closed	0 $0
Q4 2019 Jan 21, 2020	SELL	$68.3 - $93.8 $151,489 - $208,048	-2,218 Reduced 17.91%	10,168 $857,000
Q3 2019 Oct 29, 2019	SELL	$61.86 - $97.8 $427,514 - $675,895	-6,911 Reduced 35.81%	12,386 $926,000
Q2 2019 Jul 29, 2019	SELL	$42.22 - $63.23 $3,630 - $5,437	-86 Reduced 0.44%	19,297 $1.22 Million
Q1 2019 Apr 30, 2019	SELL	$31.96 - $56.12 $10,674 - $18,744	-334 Reduced 1.69%	19,383 $934,000
Q4 2018 Feb 01, 2019	SELL	$28.72 - $52.63 $30,902 - $56,629	-1,076 Reduced 5.17%	19,717 $660,000
Q3 2018 Nov 05, 2018	BUY	$32.0 - $52.4 $7,872 - $12,890	246 Added 1.2%	20,793 $1.09 Million
Q2 2018 Jul 24, 2018	BUY	$19.85 - $32.0 $407,857 - $657,504	20,547 New	20,547 $643,000

290

75.6M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.13B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.